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.0041. Introduction
In the last few years a great attention was given for Mycobac-
terium avium subsp. paratuberculosis (MAP) as its real threat is
clearly underestimated for both cattle and human. This worry
is justiﬁed as MAP could be detected in environmental sam-
ples, survives up to one year in contaminated pastures, can re-
main viable after milk pasteurization and resists the ripening
process of cheese [1]. Although MAP was ﬁrstly isolated in
Egypt in 2004 [2], yet no data are available about theaculty of Veterinary Medicine, Cairo University.
80 A. Fawzy et al.distribution, economic losses, prevalence in different species
and the epidemiology of the disease in Egypt. The pilot study
of Salem, et al. 2005 proved the widespread of MAP in Egyp-
tian farms. The high resistance of MAP to environmental fac-
tors and its difﬁcult high cost diagnosis hindered the
performance of efﬁcient control programs in Egypt. On the
other hand, the role of MAP in public health as the causative
agent of Crohn’s disease (CD) has long been debated.
Although an association between MAP and CD was reported
since 1913 [3], there is no evidence till now for neither depen-
dent causation nor independence of MAP in CD. Despite al-
most 100 years of investigation, conﬂicting data still occur
and the responsibility of MAP as the etiological agent of CD
were proven in some reports [4–6] and denied by others [7,8].
Meanwhile, some researchers incriminated certain but not all
MAP genotypes to induce the disease [1,9]. Others detected
MAP as a co-factor with other pathogens such as Pseudomo-
nas, Campylobacter, Listeria, Brucella and Yersinia or other
factors such as fragments of dead bacteria, immune dysregula-
tion, genetic predisposing factors, smoking and even certain
elements of food in the induction of CD [10–14].
This study was conducted to identify the areas at risk in
Nile delta and the level of that risk and to investigate both inci-
dence and correlation of MAP and CD among attendants on
epidemiological, serological and molecular biological basis.2. Materials and methods
2.1. Samples, human patients and controls
Serum samples were collected from 435 apparently healthy ani-
mals (3–8 years old) during the period from June 2009 till July
2010 to be screened for the presence of MAP (Table 1). These
samples represent multiple ruminant species that were raised in
some Egyptian governorates with previous history of MAP
infection [2]. In the same period and from same governorates,
sera of 366 humans were collected from individuals that do or
do not have contact with farm animals to be screened for the
presence of M. avium subsp. paratuberculosis and anti-Saccha-
romyces cerevisiae antibodies.
Five patients undergoing a routine ileocolonoscopy as a
normal part of their clinical care were also enrolled in the
study. Serum and mucosal biopsies were obtained from all
patients. Informed consent was obtained from each individual.
The case deﬁnition of CD was established on the basis of stan-
dard clinical, radiological, endoscopic, and histopathological
criteria. Paired biopsy specimens were obtained from the ter-
minal ileum and colon particularly from inﬂamed oedematous
mucosa and not from the ﬂoor of the ulcers, as it may be ﬁbro-
tic [15]. Each mucosal sample was taken from the biopsy for-
ceps with a sterile needle and transferred to a 1.5-ml sterile
screw-cap reaction tube containing 0.5 ml of sterile 0.85% sal-
ine. In addition, tissue samples were collected from ﬁve Hol-
stein cows suffering from chronic digestive disorders in a
private farm with a current paratuberculosis problem. MAP
was isolated and characterized from fecal samples collected
from these cows in an early report [16] and hence were selected
to be included. These cows were brought to the regional
slaughter house for culling purpose. Paired samples were
obtained (approximately same size as human biopsies) from
inﬂamed oedematous mucosa of the terminal ileum and colonby sterile scissor and forceps and were transferred in 1.5-ml
sterile screw-cap reaction tubes containing 0.5 ml of sterile
0.85% saline.
All tissue samples were not frozen at any time, they were
immediately taken to the laboratory to be processed. Serum
samples were separated into aliquots of 20–1000 ll and stored
at 20 C for short-term storage (<6 months) or at 80C for
long-term storage (>6 months). Frozen specimens were mixed
well after thawing and prior to testing.
2.2. ELISA for animal and human serum antibodies to M. avium
subsp. paratuberculosis
The presence of MAP antibodies was detected in animal serum
samples using the ID Screen Paratuberculosis Indirect ELI-
SA kit (ID VET diagnostics, Montpellier, France). Results
were interpreted according to manufacturer’s instructions.
The same kit was adapted for human use. M. avium subsp.
paratuberculosis antigen-coated 96-well microtiter plates and
Mycobacterium phlei-containing serum diluent (used to absorb
cross-reactive antibodies) supplied with the kit were used. A
horseradish peroxidase-labeled protein G conjugate (Sigma,
Germany) (diluted 1:100,000 according to manufacturer’s
instructions) was used instead of conjugate supplied with the
kit, to detect binding of human antibodies to the solid-phase
M. avium subsp. paratuberculosis antigens. On each ELISA
plate positive and negative bovine and human control sera
were tested in duplicate along with bovine control sera
provided with the kit.
A commercial pool of serum from normal healthy blood do-
nors (El Rouda laboratory, Cairo, Egypt) was used as the neg-
ative human control. The human serum samples were diluted
1:20 in kit serum diluent (identical to the kit protocol for testing
bovine sera) and incubated for 30 min at room temperature
prior to transfer to themicrotiter plate. One hundredmicroliters
of each diluted control serum and serum sample was dispensed
into duplicate wells and incubated for 30 min at room temper-
ature then were removed by washing three times with phosphate
buffered saline. After removal of residual wash ﬂuid, 100 ll of
conjugate was added and the plate was incubated another
30 min. After washing the wells as before, 100 ll of TMB sub-
strate solution was added to each well and incubated for
15 min. The enzymatic reaction was stopped after 15 min by
addition of 100 ll of stop solution provided with the kit (diluted
H2SO4). The absorbance for each well was measured spectro-
phometrically at 650 nm (ELx808 Absorbance Microplate
Reader; Biotech Instruments, Inc. Winooski, VT.). Mean ELI-
SA absorbance values were transformed to sample-to-positive
(s/p) ratio as done for the cattle assay; however, absorbance val-
ues for the human sera were used as controls in the calculation s/
p = absorbance of sample  absorbance of negative control/
absorbance of positive control  absorbance of negative con-
trol. Three hundred and seventy one human serum samples
were tested from different Egyptian governorates (Nile delta,
Egypt.) for human serum antibodies to MAP were used to
establish the s/p cut-off for a positive test.
2.3. ELISA for human serum anti-S. cerevisiae antibodies
(ASCA)
Enzyme-linked immunosorbent assays for the semi-quantita-
tive detection of anti-S. cerevisiae antibodies (ASCA) of the
Table 1 Seroprevalence of MAP in investigated animal species.
Species Farm code origin Breed Import origin Nr. of samples Nr. of MAP ELISA positive Positive (%)
Cattle 1-F Fayyum Holstein USA 32 11
2-F Fayyum Holstein USA 4 4 42
1-I Ismailia Holstein USA 60 52
2-I Ismailia Holstein USA 9 2 61
3-I Ismailia Holstein USA 33 8
1-M Mansoura Holstein USA 8 2 25
SA Giza Bos taurus Egypt 3 1 66
1-Mo Monﬁa Holstein Egypt 35 19 54
1-G Gharbia Bos taurus Egypt 21 1 5
1-S Sharkia Frisian USA 28 8 29
233 108 46.4
Buﬀaloes SA Giza Bubalus bubalis Egypt 39 18
SA Giza Bubalus bubalis Egypt 1 0
SA Fayyum Bubalus bubalis Egypt 18 8
58 26 44.8
Sheep 1-A Cairo (El-Obour) Rahmani Egypt 25 17
SA Giza (Dairie) Osseimi Egypt 22 18
SA Giza Osseimi Egypt 41 6
88 41 46.6
Goat SA Giza Nubian Egypt 56 21 37.5
Total 435 196 45
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ples were tested by both the QUANTA Lite ASCA (S. cere-
visiae) IgG and IgA ELISAs as recommended by the
manufacturer (Medical Technology Promedt consulting
GmbH, Germany). In both the IgG and IgA assays, partially
puriﬁed and disrupted S. cerevisiae antigen was bound to the
wells of polystyrene microwell plates under conditions that will
preserve the antigen in its native state. Pre-diluted controls and
diluted patient sera were added to separate wells, allowing any
ASCA IgG or IgA antibodies present to bind to the immobi-
lized antigen. Unbound samples were washed away and an en-
zyme labeled anti-human IgG or IgA conjugate was added to
each well. A second incubation was performed allowing the en-
zyme labeled anti-human IgG or IgA to bind to any patient
antibodies, which have become attached to the microwells.
After washing away any unbound enzyme labeled anti-human
IgG, the remaining enzyme activity was measured by adding a
chromogenic substrate and measuring the intensity of the color
that develops. Both assays were evaluated spectrophotometri-
cally by measuring and comparing the color intensity that
develops in the patient wells with the color in the control wells.
2.4. DNA extraction for tissue samples
One tissue mucosal sample from each pair was processed for
direct IS900-speciﬁc PCR testing following the method de-
scribed by Bull and colleagues 2003 [15]. Brieﬂy, tubes contain-
ing the biopsy specimens were centrifuged at 10,000·g for
3 min. The supernatant was removed and the pellet was resus-
pended in 600 ll of mycobacterial lysis buffer (2 mM sodium
EDTA, 400 mM NaCl, 10 mM Tris HCl [pH 8.0], 0.6% so-
dium dodecyl sulfate and 33 lg of proteinase K (Sigma, Ger-
many) made up in nuclease-free water and transferred to aLysing Matrix B Ribolyser tube (Qbiogene, Noltingham, Uni-
ted Kingdom).
The Ribolyser tube was shaked at 37 C for 2 h. The tubes
were chilled on ice for 5 min and mechanically disrupted in the
FastPrep Ribolyser (Qbiogene, Noltingham, United Kingdom)
and then immediately chilled again on ice for 15 min. A vol-
ume of 600 ll of phenol (Sigma, Germany) was added and
the mixture was vortexed and then centrifuged at 10,000·g
for 1 min. The aqueous layer was transferred to a new screw-
cap reaction tube containing an equal volume of phenol-chlo-
roform-isoamyl alcohol (25:24:1) (Sigma Germany), and the
mixture was saturated in 1· TE and centrifuged (10,000g for
1 min). The aqueous layer was again transferred to a new tube
containing chloroform-isoamyl alcohol (24:1), vortexed and
centrifuged (10,000g for 1 min). The ﬁnal aqueous layer was
transferred to a new tube containing 90 ll of 10 M ammonium
acetate and mixed thoroughly. One milliliter of ice-cold 100%
ethanol was added to enable DNA precipitation at room tem-
perature for 1 h. Samples were then centrifuged (10,000g for
20 min) and the pellets were washed in ethanol. The pellets
were dried at RT for 30 min, resuspended in 50 ll of 1· TE.
2.5. Culture of biopsy specimens
The second of each pair of biopsy specimens from each tissue
sample was decontaminated when fresh and subsequently cul-
tured in separate HEYM tubes at 37 C for up to 20 months.
Brieﬂy, 0.5 L of NaOH–N-acetyl-L-cysteine (BBL Mycoprep;
Becton Dickinson) was added to each sample in 0.5 ml of sal-
ine, and the mixture was incubated at RT for 20 min. The sam-
ples were then centrifuged (10,000g for 10 min). The pellet was
resuspended in 0.5 ml of TEN buffer (2 mM sodium EDTA,
400 mM NaCl, 10 mM Tris HCl [pH 8.0]; Sigma) and
Table 2 Chi-squared test for assessment of sheep breed as
being risk factor of seropositivity for paratuberculosis.
Total ELISA negative ELISA positive Sheep breed
25 (a+b) 8 (b) 17 (a) Rahmani
63 (c+d) 39 (d) 24 (c) Osseimi
88 (N) 47 (b+d) 41 (a+c) Total
(a) ELISA positive Rahmani sheep, (b) ELISA negative Rahmani
sheep, (c) ELISA positive Osseimi sheep, (d) ELISA negative
Osseimi sheep. (N) Total number of sheep.
82 A. Fawzy et al.transferred to 4 HEYM slants supplied with mycobactin J
(Becton Dickinson). After incubation at 37 C for between
14 and 50 weeks, cultures with visible growth were removed
aseptically for testing by the IS900-speciﬁc nested PCR as de-
scribed below. Acid-fast colonies were subcultured onto
HEYM tubes with and without mycobactin J.
2.6. IS900 nested PCR assay
The primer set used in this PCR was the primer pair TJ1 (50
GCT GAT CGC CTT GCT CAT 30), TJ2 (50 CGG GAG
TTT GGT AGC CAG TA 30) in the ﬁrst-round PCR and pri-
mer pair TJ3 (50 CAG CGG CTG CTT TAT ATT CC 30),
TJ4 (50 GGC ACG GCT CTT GTT GTA GT 30) in the nested
PCR [15]. In the ﬁrst-round PCR the primers were used in a ﬁnal
concentration each of 2 lM in a 50 ll PCR reaction master mix
which also included 1.25 U Taq polymerase, 1· PCR buffer,
1.5 mM MgCl2, 200 lM dNTP mix and 5 ll of isolated DNA.
The thermal cycler parameters used for ampliﬁcation included
an initial 95 C incubation step for 10 min for Taq polymerase
activation followed by 30 cycles of denaturation at 95 C for
1 min, annealing at 58 C for 1 min and extension at 72 C for
2 min with a ﬁnal extension step at 72 C for 10 min. The ampli-
ﬁcation products (357 bp) were visualized on a UV transillumi-
nator after electrophoresis at 125 V for 45 min in 1.5% agarose
gels pre-stained with ethidium bromide.
For the nested PCR, 5 ll of the ﬁrst-round reaction mixture
were transferred into a 45-ll reaction mixture that had the
same ingredients as the primary reaction mixture but with
2 lM (each) primers from the primer pair TJ3 and TJ4. Cy-
cling conditions were 1 cycle of 95 C for 5 min and then 40 cy-
cles of 95 C for 1 min, 58 C for 1 min, 72 C for 2 min
followed by 1 cycle of 72 C for 10 min. Amplicons of the ex-
pected size (294 bp) were visualized with ethidium bromide on
1.5% agarose gels. In each PCR run, negative controls were
tested in triplicate containing 5 ll of the buffer used to elute
the DNA, 5 ll sterile bi-distilled water and 5 ll DNA from a
coded sample that has shown to be IS900-speciﬁc PCR nega-
tive. While positive control tubes (n= 2) included 5 ll DNA
fromMap the 19698 strain and 5 ll DNA from a coded sample
that has shown to be IS900-speciﬁc PCR positive.
2.7. Statistical analysis
Chi-squared test was used for assessment of risk of paratuber-
culosis seropositivity in sheep associated with breed
susceptibility.
Kappa statistics were used to determine agreement between
modiﬁed MAP and ASCA ELISAs as diagnostic tools for Cro-
hn’s disease in humans.
3. Results and discussion
MAP represents a serious problem since its ﬁrst report in dif-
ferent governorates of Egypt [17]. The result obtained in this
study highlights the increased incidence of MAP infection in
Egypt that might lead to severe economic losses to ruminant
industry and might also be a future threat to public health.
All human and animal sera included in the present work were
collected in the period from June 2009 till July 2010 at a single
time-point from apparently healthy individuals. Testedanimals and human individuals originated from the same
Egyptian governorates that had a known history of paratuber-
culosis infection and were subjected to screening of MAP using
ELISA in order to assess the human/animal risk at a single
time point. Out of 435 animal serum samples, 45.2% were
MAP ELISA positive. On the species level, 109 out of 233
dairy cattle were ELISA positive with a percentage of 46.6%.
This percentage is higher than previous reports [18–20]. The
revealed high percentages may be due to bias by investigating
paratuberculosis-suspected farms. Twenty six out of 58 buffalo
serum samples were ELISA positive with a percentage of
44.8% that was higher than that reported by Singh et al. [6]
(28.6%) for buffaloes in Northern India. Forty one out of 88
sheep serum samples were ELISA positive with a percentage
of 46.5% that was signiﬁcantly higher than that reported by
Anna et al. [21] (6.29%) for sheep belonging to two provinces
in central Italy. Twenty one out of 56 goat serum samples were
ELISA positive with a percentage of 37.5% that was higher
than that reported by Lee et al. [22] (15.3%) for black goats
in some regions of Korea and Mercier et al. [23] (2.9%) for
dairy goats in France. The detection of MAP antibodies in
investigated apparently healthy animals emphasizes the role
of subclinical animals in the spread of the disease.
Paratuberculosis was detected in water buffalo (Bubalus
bubalis) in Indian subcontinent by different diagnostic tech-
niques including ELISA [6], PCR [24], and culture [25]. The
Egyptian water buffaloes (Bubalus bubalis) included in this
study showed serological evidence of paratuberculosis
infection.
For sheep samples, the seroprevalence is the highest in Dai-
rie locality, Giza, Egypt (82%) and this might be attributed to
the fact that sheep reared in this locality has replaced pigs in
the elimination of organic wastes that include fecal matters
of different animals, which will subject these animals to differ-
ent pathogens specially those caused by robust microorgan-
isms like MAP. The seroprevalence in El-Obour locality,
Cairo, Egypt is 68% and this may be due to close contact of
sheep in this locality with imported cattle. With the regard
to governorate-based and breed-based seropositivity, it was
found that seropositivity was higher in Cairo (68%, 17 out
of 25 Rahmani sheep) than in Giza (38%, 24 out of 63 Osseimi
sheep). Assessment of breed as a probable risk factor of para-
tuberculosis seropositivity revealed a chi-squared value (v2) of
6.43 (Table 2).
The corresponding p-value (probability value) was deter-
mined to be 0.01 in the chi-squared table, when the value of de-
grees of freedom is one. The obtained p-value is less than the
signiﬁcant cutoff value (0.05); consequently sheep breed is a
probable statistically signiﬁcant risk factor of paratuberculosis
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Epidemiological studies on Johne’s disease in ruminants 83seropositivity; however, other factors may contribute to this
highly signiﬁcant difference provided that the two different
breeds were reared under different environmental conditions
and probably different exposure rates.
The seroprevalence of MAP among foreign breeds of cattle
seems to be higher than others. Animals reared in Ariaf Imb-
aba and reared in sporadic form have the lowest prevalence.
This may be attributed to the nature of this disease as an exotic
disease that was recently introduced to Egypt [17]. In addition,
most of the examined cattle (reared in large farms in Egypt) are
imported from USA, Germany, Canada or other countries fac-
ing a problem with MAP [26].
With regard to governorate-based seropositivity, the high-
est percentage of cattle seropositivity to paratuberculosis was
detected in Ismailia governorate (66%), followed by Monoﬁa
(54%) while seropositivity in other tested governorates
(Fayoum, Giza, Sharkeya, Mansoura and Gharbia) ranged
from 42% to 5% (Table 1). These relatively high positive per-
centages of the ELISA in investigated localities may be attrib-
uted to bias resulting from inclusion of a few numbers of dairy
cattle herds previously suspected of having paratuberculosis
infection.
In the last decade, there was a growing debate about the
possible link between Crohn’s disease in human and MAP
infection. In the present work, we investigated the correlation
between JD and CD based on three bases; epidemiological,
serological and molecular biological. From the serological
point of view, ASCA are antibodies primarily directed against
a 200 kD a phosphopeptidomannan cell wall component of the
common baker’s or brewer’s yeast Saccharomyces (S. cerevisi-
ae). ASCA reactivity could be the result of cross-reacting anti-
bodies to antigens found in a non-yeast organism that has not
yet been identiﬁed. Mannose is not only found in yeast but also
in mycobacteria and other microorganisms [27]. According to
the international incidence rate, ASCA are found in 39–69%
of CD patients [28]. Interestingly, the sensitivity of ASCA
IgA was reported to be lower in Japanese and Chinese CD pa-
tients when compared to Caucasian CD patients suggesting
that the ASCA response may be inﬂuenced by several distinct
genetic determinants and/or environmental risk factors [27].
In Egypt, according to our data (Tables 3–5), the number of
ASCA positive cases is above the detected MAP seropositive
human cases in the population. Twenty three out of 371 hu-
man serum samples were positive when investigated for the
presence of MAP antibodies using indirect modiﬁed ELISA
with a positive percentage of 6.1% which was lower than that
reported by Bernstein et al. [29] (35%).
A positive human serum was deﬁned based on human sera
collected from different Egyptian governorates as the mean
plus 2 standard deviations, which by deﬁnition gave the assay
94% speciﬁcity. Whereas 37 out of 371 human serum samples
were positive for either ASCA IgG or ASCA IgA ELISAs or
for both, with a positive percentage of 9.9%. Agreement be-
tween modiﬁed MAP and ASCA ELISAs was calculated to
be 0.036 by kappa statistics (Table 6), which indicates poor
agreement between both tests and supposes either a weak or
no relationship between Crohn’s disease in humans and
MAP infection based on serological status and may indicate
that Crohn’s is a multifactorial disease in which MAP plays
a minor rule or has no role.
Although the diagnosis of CD depends on ASCA ELISA in
combination with colonoscopy, yet only two patients out of 5
Table 4 Human serum samples: number of ASCA positive, number of MAP ELISA positive and number of both MAP and ASCA
positive samples.
Origin Total Number ASCA positive MAP positive MAP and ASCA positive
Cairo 122 20 5 1
Giza 94 10 7 2
60 4 1 0
5 2 2 1
Nile delta 90 1 8 0
Total 371 37 23 4
Table 5 Human samples according to sex and to animal contact.
Females Males Human – no contact with farm animals Human – in contact with farm animals
MAP ELISA positive 11/170
(6.4%)
12/201
(5.9%)
6/182
(3.2%)
17/189
(8.9)
ASCA ELISA positive 14/170
(8.2%)
23/201
(11.9%)
24/182
(13.1%)
13/189
(6.8%)
Table 6 Agreement between MAP and ASCA ELISAs on human sera.
Total ASCA ELISA Neg.^ ASCA ELISA Pos.*
27 23 4 MAP ELISA Pos.
344 307 37 MAP ELISA Neg.
n= 371 330 41 Total
* Positive for either ASCA IgG or IgA or both.
^ Negative for both ASCA IgG and IgA.
Table 7 Bacteriological and molecular biological detection of MAP in examined cattle tissue samples and human intestinal biopsies.
Tissue origin IS900 nested PCR Culture Culture-ZN stain Culture IS900 PCR
Human (n= 5) 0/5 0/5 ND ND
Cattle (n= 5) 5/5 5/5 5/5 5/5
ZN: Ziehl–Neelsen, ND: not done.
84 A. Fawzy et al.CD conﬁrmed cases were ASCA positive (40%). This indicates
the low detection level of ASCA and conﬁrms that CD may
have different causes and cannot be detected with a single test.
Moreover, the prevalence of MAP antibodies among humans
is clearly lower than in animals. This may be either due to
the recent introduction of MAP to Egypt (ﬁrst reported in
2005 while it is a well-known disease in other countries export-
ing cattle to Egypt), or the low susceptibility of Humans to
MAP. It is also of great importance to mention that most of
the infected cattle were either imported from MAP endemic
countries or were born in Egypt in contaminated farms [26].
Some literature suppose the susceptibility of human to cer-
tain but not all strains of MAP, which may be the cause of this
lower seroprevalence in comparison to animals [9]. The ob-
tained data showed also that the prevalence of MAP in human
without contact with animals was 3.2% compared to 8.9% in
those with contact with animals. Additionally, there was no
big difference in susceptibility between females and males6.4% compared to 5.9% and this might reveal the susceptibil-
ity of human to MAP direct infection from animals.
In this work, we could not detect MAP by traditional bac-
teriological and molecular biological methods in Crohn’s suf-
ferers surgically dissected intestinal sections. Contradictory it
was very easy to detect the bacteria in all clinical cases of JD
when processed using the same protocols (Table 7). One of ﬁve
human patients previously diagnosed as Crohn’s sufferers
tested positive with both ASCA IgG and MAP ELISAs. Nev-
ertheless, no MAP or MAP DNA could be detected in biopsies
obtained from these ﬁve patients by IS900 nested PCR and/or
culture method. On the other hand, all ﬁve tissue samples col-
lected from clinically affected cattle showed positive IS900
PCR results and colonies growth of typical morphological
characteristics of MAP including greyish white color and pin-
point half-balled shape.
These colonies were further characterized based on Ziel
Nielsen stain, mycobactin J dependency and IS900 PCR [26].
Epidemiological studies on Johne’s disease in ruminants 85This may indicate, either that there is no relationship between
CD and JD or that CD is a multi-factorial disease and can be
induced by various causes including MAP [30]. Such low detec-
tion sensitivity of culture of human biopsies might be attrib-
uted to the low detection sensitivity of the standard culture
technique and other culture protocols and/or media like the
MGIT or the Bactec system might be needed for the successful
isolation of MAP from surgically dissected human biopsies.
Additionally, some human isolates may take up to six years
to grow even under standard culture and decontamination
conditions [26]. On the contrary, some laboratories reported
the successful isolation of MAP not only from Crohn’s suffer-
ers intestine, but also from human patients blood and breast
milk samples [31].
4. Conclusion
Although different techniques were used, the comparison of
the obtained data in the current study with that from our pre-
vious report in 2005 indicates the increase in disease incidence
in animals [2]. So an effective control program is needed in or-
der to prevent the spread of MAP infection on both local and
national level in Egypt. The detection of MAP antibodies in
investigated apparently healthy animals emphasizes the role
of subclinical animals in the spread of the disease. There was
a serological evidence of paratuberculosis infection among dif-
ferent species of livestock included in this study necessitating a
more comprehensive monitoring of the disease among differ-
ent animal species in Egypt. Sheep breed was found to be a
probable statistically signiﬁcant risk factor of seropositivity
to paratuberculosis with Rahmani breed being more suscepti-
ble than Osseimi one, taking into consideration that the two
different breeds were reared under different conditions. Egyp-
tian water buffaloes showed seropositivity to MAP antigen;
however the epidemiological role of buffaloes should be fur-
ther investigated. A very weak relationship between MAP
and Crohn’s disease in humans was revealed in the current
work.
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